Having MS I follow the research news (see National MS
Society website to find listings). The good news is
that there are many "promising" treatments, including
this one. However the press release descibes the result
of a "Phase I" study, which by definition is an experiment
to determine the _safety_ of a new treatment, not its
efficacy. Most candidate treatments that do OK
in their Phase I study, fail in their Phase II and Phase III
studies. Only 3(4) drugs have run the gauntlet and
are in use for non-experimental treatment (one is
available only under special conditions). The role
of various cells of the immune system, of myelin
destruction and other (unknown) neurodegenerative
processes, the cause, and much more are hotly
debated in the research literature. Myself, I'm
insisting on both a cure AND a method to
repair the damage already done. So there!